GFAFX
Price
$87.11
Change
+$0.79 (+0.92%)
Updated
Aug 21 closing price
Net Assets
342.42B
MIGKX
Price
$42.07
Change
+$0.21 (+0.50%)
Updated
Aug 21 closing price
Net Assets
8.65B
Interact to see
Advertisement

GFAFX vs MIGKX

GFAFX vs MIGKX Comparison Chart in %
View a ticker or compare two or three
VS
GFAFX vs. MIGKX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFAFX is a StrongBuy and MIGKX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFAFX has more cash in the bank: 342B vs. MIGKX (8.65B). MIGKX pays higher dividends than GFAFX: MIGKX (0.65) vs GFAFX (0.21). GFAFX was incepted earlier than MIGKX: GFAFX (25 years) vs MIGKX (21 years). GFAFX (0.65) is less costly to investors than MIGKX (0.46). GFAFX is a more actively managed with annual turnover of: 32.00 vs. MIGKX (21.00). MIGKX has a lower initial minimum investment than GFAFX: MIGKX (0) vs GFAFX (250). GFAFX annual gain was more profitable for investors over the last year : 5.50 vs. MIGKX (-5.58). GFAFX return over 5 years is better than : 17.03 vs. MIGKX (-2.16).
GFAFXMIGKXGFAFX / MIGKX
Total Expense Ratio0.650.46141%
Annual Report Gross Expense Ratio0.650.46141%
Fund Existence25 years21 years-
Gain YTD9.407-0.071-13,202%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets342B8.65B3,952%
Annual Yield % from dividends0.210.6532%
Returns for 1 year5.50-5.58-99%
Returns for 3 years47.0613.05361%
Returns for 5 years17.03-2.16-787%
Returns for 10 years101.3176.68132%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMIYX31.100.31
+1.01%
Lord Abbett Micro Cap Growth I
TGIWX16.140.08
+0.50%
Nuveen Core Equity W
BCSVX22.530.07
+0.31%
Brown Capital Mgmt Intl Sm Co Inv
IBARX27.410.05
+0.18%
Nomura Balanced Fund Class R6
FAPKX14.20N/A
N/A
Fidelity Advisor Healthy Future C